Work

Obecabtagene autoleucel, a novel CD19-directed CAR T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: the future for reducing toxicity and T-cell exhaustion?

Year: 2025

Type: review

Source: Expert Review of Hematology

DOI: 10.1080/17474086.2025.2523551

Authors: Jean A. Yared, Ariel Fromowitz, Mehmet Kocoglu, Nancy Hardy, Djordje Atanackovic, Aaron P. Rapoport

Institutions: University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411545467

FWCI: 0.827

Cites: 27

Cited by: 7

Related to: 10